Related references
Note: Only part of the references are listed.Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial
Jim Aizire et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2020)
Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir
Kristina M. Brooks et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus
Angela Colbers et al.
CLINICAL INFECTIOUS DISEASES (2019)
Reduced exposure to darunavir and cobicistat in HIV-1-infected pregnant women receiving a darunavir/cobicistat-based regimen
H. M. Crauwels et al.
HIV MEDICINE (2019)
Cobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint
Sarita D. Boyd et al.
AIDS (2019)
Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017
Kathleen M. Powis et al.
JAMA NETWORK OPEN (2019)
Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV
Jeremiah D. Momper et al.
AIDS (2018)
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2018 Recommendations of the International Antiviral Society-USA Panel
Michael S. Saag et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Safety of Tenofovir Disoproxil Fumarate–Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants
Jean B. Nachega et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus
Adrian S. Ray et al.
ANTIVIRAL RESEARCH (2016)
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
M. G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study
Aizati N. A. Daud et al.
DRUG SAFETY (2015)
Pharmacokinetics of tenofovir during pregnancy and postpartum
B. M. Best et al.
HIV MEDICINE (2015)
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women
Alice Stek et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
Paul E. Sax et al.
LANCET (2015)
Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta
Zuzana Neumanova et al.
AIDS (2014)
Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults
Martin Markowitz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Renal Physiology of Pregnancy
Katharine L. Cheung et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2013)
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women
Angela P. H. Colbers et al.
AIDS (2013)
Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults
Peter J. Ruane et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Mechanism for Effective Lymphoid Cell and Tissue Loading Following Oral Administration of Nucleotide Prodrug GS-7340
Darius Babusis et al.
MOLECULAR PHARMACEUTICS (2013)
Alteration of the Expression of Pesticide-Metabolizing Enzymes in Pregnant Mice: Potential Role in the Increased Vulnerability of the Developing Brain
Marie C. Fortin et al.
DRUG METABOLISM AND DISPOSITION (2013)
Pregnancy-Related Effects on Tenofovir Pharmacokinetics: a Population Study with 186 Women
Sihem Benaboud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Cobicistat Boosts the Intestinal Absorption of Transport Substrates, Including HIV Protease Inhibitors and GS-7340, In Vitro
Eve-Irene Lepist et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Pharmacokinetic Optimization of Antiretroviral Therapy in Pregnancy
Kajal Buckoreelall et al.
CLINICAL PHARMACOKINETICS (2012)
Pharmacokinetics of oseltamivir among pregnant and nonpregnant women
Richard H. Beigi et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants
Patricia M. Flynn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Lopinavir Tablet Pharmacokinetics With an Increased Dose During Pregnancy
Brookie M. Best et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission
Charles S. Chasela et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: A University of Washington specialized center of research study
M. F. Hebert et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: Mechanisms, tissue specificity, and time course
Huixia Zhang et al.
MOLECULAR PHARMACOLOGY (2008)
Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptors
Honggang Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue
WA Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Share Paper
